Reference Source

Rapiflex Distribution · 66-41 · CANADA

For Rapiflex Distribution · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product is OSMOPAK PLUS; product code is 61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment; date published is 09/30/2009; address is 1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA, verified against its source on 2026-09-16.

Firm
Rapiflex Distribution verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CANADA verified
Address
1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA verified
Date published
09/30/2009 verified
Product code
61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment verified
Product
OSMOPAK PLUS verified
FDA notes
Shipper - This product is used as a drawing salve for the inflammation of subcutaneous tissues.; 3/26/1998 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Rapiflex Distribution Date Published : 09/30/2009 1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA 61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment Date Published: 09/17/2019 Desc: OSMOPAK PLUS Notes: Shipper - This product is used as a drawing salve for the inflammation of subcutaneous tissues.; 3/26/1998

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.